BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

Bot Chart, page-14780

  1. 2,128 Posts.
    lightbulb Created with Sketch. 1508
    .... there is a risk that the co-pay or deductible would not cover the viability of the regular use of Sofdra.

    Not according to the info BOT have shared previously. They have indicated that based on other co-pay arrangements for similar medications, they anticipate wide and in-depth coverage of Sofdra by Insurers. These BOT guys know the game, so I don't doubt they have it covered.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.